4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICING FOR US HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT (2024)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON US HEALTHCARE ANALYTICS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN US HEALTHCARE ANALYTICS MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN US HEALTHCARE ANALYTICS MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN US HEALTHCARE ANALYTICS MARKET
7.1
REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
US HEALTHCARE ANALYTICS MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
9.2.1.1
ANALYTICAL SERVICES
9.2.1.2
CONSULTING SERVICES
9.2.2
PROFESSIONAL SERVICES
9.2.2.1
TRAINING & IMPLEMENTATION
9.2.2.2
MAINTENANCE & SUPPORT SERVICES
9.2.2.3
OTHER PROFESSIONAL SERVICES (IF ANY)
9.2.1
ON-PREMISE SOFTWARE
9.2.2
CLOUD-BASED SOFTWARE
10
US HEALTHCARE ANALYTICS MARKET, BY TYPE (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
10.2
DESCRIPTIVE ANALYTICS
10.3
PREDICTIVE ANALYTICS
10.4
PRESCRIPTIVE ANALYTICS
10.5
DIAGNOSTIC ANALYTICS
11
US HEALTHCARE ANALYTICS MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
11.2.2
REVENUE CYCLE MANAGEMENT
11.2.3
PAYMENT INTEGRITY FRAUD, WASTE, AND ABUSE (FWA)
11.2.4
RISK ADJUSTMENT & ASSESSMENT
11.3.1
QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
11.3.2
CLINICAL DECISION SUPPORT
11.3.3
REPORTING & COMPLIANCE
11.3.4
COMPARATIVE ANALYTICS/EFFECTIVENESS
11.3.5
PRECISION HEALTH/REAL-WORLD EVIDENCE
11.3.6
MEDICAL IMAGING ANALYTICS
11.4
OPERATIONAL & ADMINISTRATIVE ANALYTICS
11.4.1
SUPPLY CHAIN ANALYTICS
11.4.2
WORKFORCE ANALYTICS
11.4.3
STRATEGIC ANALYTICS
11.5
POPULATION HEALTH ANALYTICS
12
US HEALTHCARE ANALYTICS MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
12.2.1
PRIVATE INSURANCE COMPANIES
12.2.2
GOVERNMENT AGENCIES
12.3.1
HOSPITALS AND CLINICS
12.3.2
POST-ACUTE CARE ORGANIZATIONS
12.3.3
AMBULATORY SURGERY CENTERS
12.3.4
OTHER PROVIDERS (ACOS, HIES, MCOS, AND TPAS)
12.4
PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
12.4.2
DISTRIBUTORS AND WHOLESALERS
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
13.3
REVENUE ANALYSIS (2020-2024)
13.4
MARKET SHARE ANALYSIS (2024)
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.6.5.1
COMPANY FOOTPRINT
13.6.5.2
COMPONENT FOOTPRINT
13.6.5.4
APPLICATION FOOTPRINT
13.6.5.5
END-USER FOOTPRINT
13.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.7.1
PROGRESSIVE COMPANIES
13.7.2
RESPONSIVE COMPANIES
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.8
COMPANY VALUATION AND FINANCIAL METRICS
13.9
COMPETITIVE SCENARIO
13.9.4
OTHER DEVELOPMENTS
14.1.4
SAS INSTITUTE INC.
14.1.6
MCKESSON CORPORATION
14.1.12
MEDEANALYTICS, INC.
14.1.14
EXLSERVICE HOLDINGS, INC.
14.1.17
KOMODO HEALTH, INC.
14.2.1
ARCADIA SOLUTIONS, LLC
14.2.4
EVIDATION HEALTH, INC.
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY PRIMARY PARTICIPANTS
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.4
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.2.1
BOTTOM-UP APPROACH
15.2.3
BASE NUMBER CALCULATION
15.3
MARKET FORECAST APPROACH
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in US Healthcare Analytics Market